Home / CAP1 Knockout Cell Lines

CAP1 Knockout Cell Lines

Gene: CAP1

Official Full Name: cyclase associated actin cytoskeleton regulatory protein 1provided by HGNC

Gene Summary: The protein encoded by this gene is related to the S. cerevisiae CAP protein, which is involved in the cyclic AMP pathway. The human protein is able to interact with other molecules of the same protein, as well as with CAP2 and actin. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2016]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO31805 CAP1 Knockout cell line (HeLa) Human CAP1 1:3~1:6 Negative Online Inquiry
KO31806 CAP1 Knockout cell line (HCT 116) Human CAP1 1:2~1:4 Negative Online Inquiry
KO31807 CAP1 Knockout cell line (HEK293) Human CAP1 1:3~1:6 Negative Online Inquiry

Background

CAP1 Gene Knockout Cell Lines are specialized cellular models designed for the study of the CAP1 gene, which encodes cytoskeletal proteins critical for various cellular processes, including cell migration, adhesion, and signaling. These cell lines are meticulously engineered using CRISPR-Cas9 gene editing technology to provide researchers with a powerful tool for investigating the functional implications of CAP1 depletion in a controlled environment.

The key function of CAP1 Gene Knockout Cell Lines lies in their ability to enable comprehensive analysis of the physiological and biochemical changes that occur following the absence of the CAP1 protein. By studying these alterations, researchers can gain significant insights into the role of CAP1 in cellular architecture, tumorigenesis, and other pathophysiological conditions. The knockout models allow scientists to assess changes in signal transduction pathways, cell proliferation rates, and migratory behavior, therefore facilitating a deeper understanding of both normal biology and disease mechanisms.

Scientifically, these cell lines are invaluable in both research and clinical settings, particularly in the fields of cancer biology, developmental biology, and immunology. They can serve as a foundation for drug development, as researchers look to identify novel therapeutic targets by elucidating CAP1's role in disease processes. Moreover, these cell lines enable high-throughput screening and are suitable for various assays, including Western blotting and flow cytometry.

The advantages of CAP1 Gene Knockout Cell Lines include their specificity and precision compared to alternative gene editing methods like RNA interference, which may yield off-target effects or incomplete knockdown. Additionally, these knockout cell lines are readily accessible for a wide range of cellular assays, increasing their utility for laboratories with diverse research interests. Their consistent performance and reproducibility further enhance their appeal, ensuring that researchers can derive reliable data.

In summary, CAP1 Gene Knockout Cell Lines represent a significant advancement in the study of gene function, providing researchers and clinicians with tools that are both versatile and powerful. Our company's expertise in developing high-quality and reliable biological products underscores our commitment to supporting the scientific community and driving innovation in research endeavors.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.